Stay updated on JCAR014 and Durvalumab in Lymphoma Clinical Trial
Sign up to get notified when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.

Latest updates to the JCAR014 and Durvalumab in Lymphoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRecruitment status updated to indicate enrollment has ended, and new navigation/help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added along with a revised footer label (Revision: v3.6.0); the Intervention/Treatment heading formatting is standardized by removing the spaced slash.SummaryDifference0.3%

- Check20 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, indicating a minor revision to the page content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe page revision label has been updated from v3.5.3 to v3.5.4. This represents a new release of the page's content/code, without modifying displayed study details.SummaryDifference0.0%

- Check56 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3, indicating a minor update to the page's revision history. The change does not modify visible content or user-facing features.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision updated: v3.5.2 was added and v3.5.0 was removed.SummaryDifference0.0%

- Check99 days agoChange DetectedPage revision updated from v3.4.3 to v3.5.0, indicating a minor metadata update with no changes to study details or results.SummaryDifference0.0%

Stay in the know with updates to JCAR014 and Durvalumab in Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the JCAR014 and Durvalumab in Lymphoma Clinical Trial page.